Patent details
EP3324968 Title: THERAPEUTIC COMBINATIONS OF ORALLY ADMINISTERED PACLITAXEL AND A P-GP INHIBITOR FOR THE TREATMENT OF CANCER
Basic Information
- Publication number:
- EP3324968
- PCT Application Number:
- IB2016001132
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP168273183
- PCT Publication Number:
- WO2017013490
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- THERAPEUTIC COMBINATIONS OF ORALLY ADMINISTERED PACLITAXEL AND A P-GP INHIBITOR FOR THE TREATMENT OF CANCER
- French Title of Invention:
- COMBINAISONS THÉRAPEUTIQUES DE PACLITAXEL ET D'UN INHIBITEUR DE P-GP À USAGE ORAL POUR LE TRAITEMENT DU CANCER
- German Title of Invention:
- THERAPEUTISCHE KOMBINATIONEN AUS ORAL VERABREICHTEM PACLITAXEL UND EINEM P-GP-HEMMER ZUR BEHANDLUNG VON KREBS
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 27/10/2023
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 02/11/2023
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 27/09/2023
- Unitary Effect Registration Date:
- 02/11/2023
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 21/07/2016
- Grant date:
- 27/09/2023
- EP Publication Date:
- 30/05/2018
- PCT Publication Date:
- 26/01/2017
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 27/09/2023
- EP B1 Publication Date:
- 27/09/2023
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 21/07/2036
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 20/09/2023
- Name:
- Athenex Therapeutics Limited
- Address:
- 11/F Axa Center Gloucester Road, 151, Hong Kong, China (CN)
Inventor
1
- Name:
- GLUE, Paul, William
- Address:
- New Zealand (NZ)
2
- Name:
- FETTERLY, Geralk, J.
- Address:
- United States (US)
3
- Name:
- KWAN, Min-fun, Rudolf
- Address:
- United States (US)
4
- Name:
- JACKSON, Christopher Glyn Charles, Alexander
- Address:
- New Zealand (NZ)
5
- Name:
- KRAMER, E., Douglas
- Address:
- United States (US)
6
- Name:
- HUNG, Cheung-tak
- Address:
- New Zealand (NZ)
Priority
- Priority Number:
- 201562195243 P
- Priority Date:
- 21/07/2015
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 31/475; A61K 31/337; A61P 35/00; A61K 31/4725; A61P 35/02;
Publication
European Patent Bulletin
1
- Issue number:
- 202339
- Publication date:
- 27/09/2023
- Description:
- Grant (B1)
2
- Issue number:
- 202349
- Publication date:
- 06/12/2023
- Description:
- Unitary Effect Request Receipt
3
- Issue number:
- 202349
- Publication date:
- 06/12/2023
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|